Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1981 Feb;31(2):636–640. doi: 10.1128/iai.31.2.636-640.1981

Complement requirement for virus neutralization by antibody and reduced serum complement levels associated with experimental equine herpesvirus 1 infection.

D B Snyder, A C Myrup, S K Dutta
PMCID: PMC351356  PMID: 6260672

Abstract

Pony foals, negative for detectable serum-neutralizing antibody to equine herpesvirus 1 by the standard tube-culture virus neutralization test, were experimentally infected with equine herpesvirus 1. Complement-requiring (CR) and non-complement-requiring (NCR) serum-neutralizing antibodies were evaluated in preinfection and postinfection sera by means of a complement-enhanced plaque reduction assay. Low levels of CR antibodies were found in the preinfection sera of only group II ponies. Upon infection, CR antibodies were detected by day 2 postinfection and reached peak titers between 7 and 14 days postinfection in the antisera of all ponies. NCR antibodies were detected later than CR antibodies and at levels approximately 40 to 150 times lower than the latter. CR/NCR ratios indicated that complement requirement was greatest early in the acute stages of disease and that this requirement decreased during the convalescent phase. Fractionation of 1-week and 2-week postinfection antisera of group I ponies indicated the CR antibody activity resided in both the 7S and 19S fractions. Total serum complement levels of the ponies were quantified throughout the infection with an equine anti-goat erythrocyte hemolytic system. In vivo, complement levels were depressed for all ponies during the first 2 weeks of infection. A decline in complement levels was seen as early as day 2, and they decreased to an average of 35% of preinfection levels on day 10 postinfection for all ponies.

Full text

PDF
636

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bokisch V. A., Top F. H., Jr, Russell P. K., Dixon F. J., Müller-Eberhard H. J. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med. 1973 Nov 8;289(19):996–1000. doi: 10.1056/NEJM197311082891902. [DOI] [PubMed] [Google Scholar]
  2. Graham B. J., Minamishima Y., Dresman G. R., Haines H. G., Benyesh-Melnick M. Complement-requiring neutralizing antibodies in hyperimmune sera to human cytomegaloviruses. J Immunol. 1971 Dec;107(6):1618–1630. [PubMed] [Google Scholar]
  3. Grose C., Edmond B. J., Brunell P. A. Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis. 1979 Apr;139(4):432–437. doi: 10.1093/infdis/139.4.432. [DOI] [PubMed] [Google Scholar]
  4. Heineman H. S. Herpes simplex neutralizing antibody--quantitation of the complement-dependent fraction in different phases of adult human infection. J Immunol. 1967 Jul;99(1):214–222. [PubMed] [Google Scholar]
  5. Hicks J. T., Albrecht P. Cytolytic, complement-dependent antibodies to measles virus in rhesus monkeys after administration of live or killed virus. J Infect Dis. 1976 Jun;133(6):648–654. doi: 10.1093/infdis/133.6.648. [DOI] [PubMed] [Google Scholar]
  6. Hicks J. T., Ennis F. A., Kim E., Verbonitz M. The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol. 1978 Oct;121(4):1437–1445. [PubMed] [Google Scholar]
  7. Leddy J. P., Simons R. L., Douglas R. G. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera. J Immunol. 1977 Jan;118(1):28–34. [PubMed] [Google Scholar]
  8. Oldstone M. B., Cooper N. R., Larson D. L. Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement. J Exp Med. 1974 Aug 1;140(2):549–565. doi: 10.1084/jem.140.2.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Oldstone M. B., Dixon F. J. Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system. J Immunol. 1971 Nov;107(5):1274–1280. [PubMed] [Google Scholar]
  10. RICE C. E., BOULANGER P. The interchangeability of the complement components of different animal species. IV. In the hemolysis of rabbit erythrocytes sensitized with sheep antibody. J Immunol. 1952 Feb;68(2):197–205. [PubMed] [Google Scholar]
  11. RICE C. E., CROWSON C. N. The interchangeability of the complement components of different animal species in the hemolysis of sheep erythrocytes sensitized with rabbit amboceptor. J Immunol. 1950 Aug;65(2):201–210. [PubMed] [Google Scholar]
  12. Radwan A. I., Burger D. The complement-requiring neutralization of equine arteritis virus by late antisera. Virology. 1973 Jan;51(1):71–77. doi: 10.1016/0042-6822(73)90366-8. [DOI] [PubMed] [Google Scholar]
  13. Rossi C. R., Kiesel G. K. Antibody class and complement requirement of neutralizing antibodies in the primary and secondary antibody response of cattle to infectious bovine rhinotracheitis virus vaccine. Arch Virol. 1976;51(3):191–198. doi: 10.1007/BF01318023. [DOI] [PubMed] [Google Scholar]
  14. Rossi C. R., Kiesel G. K. Complement-requiring neutralizing antibodies in cattle to infectious bovine rhinotracheitis virus. Arch Gesamte Virusforsch. 1974;45(4):328–334. doi: 10.1007/BF01242876. [DOI] [PubMed] [Google Scholar]
  15. Shinkai K., Yoshino K. Complement requirement of neutralizing antibodies in different classes of immunoglobulin appearing in rabbits and guinea pigs after primary and booster immunizations with herpes simplex virus. Jpn J Microbiol. 1975 Feb;19(1):25–34. doi: 10.1111/j.1348-0421.1975.tb00844.x. [DOI] [PubMed] [Google Scholar]
  16. Skeeles J. K., Lukert P. D., De Buysscher E. V., Fletcher O. J., Brown J. Infectious bursal disease viral infections. II. The relationship of age, complement levels, virus-neutralizing antibody, clotting, and lesions. Avian Dis. 1979 Jan-Mar;23(1):107–117. [PubMed] [Google Scholar]
  17. Strunk R. C., John T. J., Sieber O. F. Herpes simplex virus infections in guinea pigs deficient in the fourth component of complement. Infect Immun. 1977 Jan;15(1):165–168. doi: 10.1128/iai.15.1.165-168.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. TANIGUCHI S., YOSHINO K. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. II. ANALYSIS OF COMPLEMENT AS THE ANTIBODY-POTENTIATING FACTOR. Virology. 1965 May;26:54–60. doi: 10.1016/0042-6822(65)90025-5. [DOI] [PubMed] [Google Scholar]
  19. Wands J. R., Mann E., Alpert E., Isselbacher K. J. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest. 1975 May;55(5):930–936. doi: 10.1172/JCI108022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wands J. R., Perrotto J. L., Isselbacher K. J. Circulating immune complexes and complement sequence activation in infectious mononucleosis. Am J Med. 1976 Feb;60(2):269–272. doi: 10.1016/0002-9343(76)90436-8. [DOI] [PubMed] [Google Scholar]
  21. Welsh R. M., Jr, Lampert P. W., Burner P. A., Oldstone M. B. Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virology. 1976 Aug;73(1):59–71. doi: 10.1016/0042-6822(76)90060-x. [DOI] [PubMed] [Google Scholar]
  22. Wilks C. R. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells. Am J Vet Res. 1977 Jan;38(1):117–121. [PubMed] [Google Scholar]
  23. YOSHINO K., TANIGUCHI S. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT. Virology. 1965 May;26:44–53. doi: 10.1016/0042-6822(65)90024-3. [DOI] [PubMed] [Google Scholar]
  24. Yoshino K., Hashimoto M., Shinkai K. Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement. Microbiol Immunol. 1977;21(4):231–241. doi: 10.1111/j.1348-0421.1977.tb00284.x. [DOI] [PubMed] [Google Scholar]
  25. Yoshino K., Kishie T. Studies on the neutralization of herpes simplex virus. VI. The mode of action of complement upon antibodysensitized virus. Jpn J Microbiol. 1973 Jan;17(1):63–70. doi: 10.1111/j.1348-0421.1973.tb00704.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES